Omalizumab for chronic urticaria: A case series and overview of the literature

Case Reports in Dermatology

Volumn 4, Issue 1, 2012, Pages 19-26

  Ivyanskiy, Ilya ^a   Sand, Carsten ^a   Thomsen, Simon Francis ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Anti IgE; Biologics; Chronic urticaria; Omalizumab

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMALIZUMAB; PLACEBO; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; CHRONIC URTICARIA; DIARRHEA; DISEASE DURATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; FLU LIKE SYNDROME; HUMAN; MEDICAL LITERATURE; MEDICAL RECORD REVIEW; MEDLINE; NAUSEA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE; UNIVERSITY; UPPER RESPIRATORY TRACT INFECTION;

EID: 84860776801     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000336205     Document Type: Article

References (30)

1. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau A, Grattan CE, Kapp A, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B, Maurer M; Dermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization: EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009;64:1417-1426.
2. Brunetti L, Francavilla R, Miniello VL, Platzer MH, Rizzi D, Lospalluti ML, Poulsen LK, Armenio L, Skov PS: High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 2004;114:922-927.
3. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B; Dermatology Section of the European Academy of Allergology and Clinical Immunology; Global Allergy and Asthma European Network; European Dermatology Forum; World Allergy Organization: EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009;64:1427-1443.
4. Vichyanond P: Omalizumab in allergic diseases, a recent review. Asian Pac J Allergy Immunol 2011;29:209-219.
5. Boyce JA: Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol 2006;117:1415-1418.
6. Spector SL, Tan RA: Effect of omalizumab on patients with chronic urticaria. Ann Allergy Asthma Immunol 2007;99:190-193.
7. Güzelbey O, Ardelean E, Magerl M, Zuberbier T, Maurer M, Metz M: Successful treatment of solar urticaria with anti-immunoglobulin E therapy. Allergy 2008;63:1563-1565.
8. Godse KV: Omalizumab in severe chronic urticaria. Indian J Dermatol Venereol Leprol 2008;74:157-158.
9. Metz M, Bergmann P, Zuberbier T, Maurer M: Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 2008;63:247-249.
10. Otto HF, Calabria CW: A case of severe refractory chronic urticaria: a novel method for evaluation and treatment. Allergy Asthma Proc 2009;30:333-337.
11. Magerl M, Staubach P, Altrichter S, Ardelean E, Krause K, Metz M, Weller K, Maurer M: Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab. J Allergy Clin Immunol 2010;126:665-666.
12. Vestergaard C, Deleuran M: Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab. Acta Derm Venereol 2010;90:443-444.
13. Krause K, Ardelean E, Kessler B, Magerl M, Metz M, Siebenhaar F, Weller K, Worm M, Zuberbier T, Maurer M: Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. Allergy 2010;65:1494-1495.
14. Waibel KH, Reese DA, Hamilton RG, Devillez RL: Partial improvement of solar urticaria after omalizumab. J Allergy Clin Immunol 2010;125:490-491.
15. Romano C, Sellitto A, De Fanis U, Esposito G, Arbo P, Giunta R, Lucivero G: Maintenance of remission with low-dose omalizumab in long-lasting, refractory chronic urticaria. Ann Allergy Asthma Immunol 2010;104:95-97.
16. Bullerkotte U, Wieczorek D, Kapp A, Wedi B: Effective treatment of refractory severe heat urticaria with omalizumab. Allergy 2010;65:931-932.
17. Sabroe RA: Failure of omalizumab in cholinergic urticaria. Clin Exp Dermatol 2010;35:e127-e129.
18. Bindslev-Jensen C, Skov PS: Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy 2010;65:138-139.
19. Al-Ahmad M: Omalizumab therapy in three patients with chronic autoimmune urticaria. Ann Saudi Me 2010;30:478-481.
20. Iemoli E, Piconi S, Fusi A, Borgonovo L, Borelli M, Trabattoni D: Immunological effects of omalizumab in chronic urticaria: a case report. J Investig Allergol Clin Immunol 2010;20:252-254.
21. Saavedra MC, Sur S: Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab. Clin Mol Allergy 2011;9:2.
22. Groffik A, Mitzel-Kaoukhov H, Magerl M, Maurer M, Staubach P: Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticaria. Allergy 2011;66:303-305.
23. Metz M, Altrichter S, Ardelean E, Kessler B, Krause K, Magerl M, Siebenhaar F, Weller K, Zuberbier T, Maurer M: Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011;154:177-180.
24. Godse KV: Omalizumab in treatment-resistant chronic spontaneous urticaria. Indian J Dermatol 2011;56:444.
25. Sánchez-Machín I, Iglesias-Souto J, Franco A, Barrios Y, Gonzalez R, Matheu V: T cell activity in successful treatment of chronic urticaria with omalizumab. Clin Mol Allergy 2011;9:11.
26. Duchini G, Bäumler W, Bircher AJ, Scherer K: Failure of omalizumab (Xolair®) in the treatment of a case of solar urticaria caused by ultraviolet A and visible light. Photodermatol Photoimmunol Photomed 2011;27:336-337.
27. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK: Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 2008;122:569-573.
28. Ferrer M, Gamboa P, Sanz ML, Goikoetxea MJ, Cabrera-Freitag P, Javaloyes G, Berroa F, Kaplan AP: Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol 2011;127:1300-1302.
29. Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Kleine-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Schäkel K, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P: Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol 2011;128:202-209.e5.
30. Saini S, Rosen KE, Hsieh HJ, Wong DA, Conner E, Kaplan A, Spector S, Maurer M: A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol 2011;128:567-573.e1.